Brixadi (buprenorphine) Subcutaneous Injection, 128 mg Monthly Prefilled Syringe, 0.36 mL, Each
Brixadi is a brand-name prescription medication containing buprenorphine, an opioid partial agonist used for the treatment of moderate to severe opioid use disorder. This formulation is a 128 mg extended-release subcutaneous injection administered once monthly, supplied as a single-dose prefilled syringe containing 0.36 mL. It is intended for use in a healthcare setting as part of a comprehensive treatment plan.
Vendor Pricing Comparison
Sorted by lowest price · Add now, sign in at checkout
Vendor Pricing Comparison
Sorted by lowest price · Add now, sign in at checkout
Brixadi is a brand-name prescription medication containing buprenorphine, an opioid partial agonist used for the treatment of moderate to severe opioid use disorder. This formulation is a 128 mg extended-release subcutaneous injection administered once monthly, supplied as a single-dose prefilled syringe containing 0.36 mL. It is intended for use in a healthcare setting as part of a comprehensive treatment plan.
1 vendor
